FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly ophthalmology, and aims at conservative treatment of dacryostenosis. Ofloxacin ophthalmic gel is introduced into a lachrymal duct. Ofloxacin ophthalmic gel 3ml is introduced every second day, 8-10 times.
EFFECT: method provides recovered patency of the lachrymal ducts and prevented recurrent postoperative stenosis following dacryorhinocystostomy, including due to mechanical dilatation of the duct by means of the gel the physical characteristics of which differ from those of tears.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CONSERVATIVE TREATMENT OF DACRYOSTENOSIS | 2012 |
|
RU2473335C1 |
METHOD OF TREATING PARTIAL DACRYOSTENOSIS | 2014 |
|
RU2557423C1 |
METHOD OF TREATING ACTINOMYCOSIS OF LACHRYMAL PASSAGES | 2009 |
|
RU2402304C1 |
DIAGNOSTICS METHOD FOR DACRYOSTENOSIS STAGES | 2007 |
|
RU2342657C1 |
METHOD OF RESTORING PASSABILITY OF LACRIMARY TRACTS | 2023 |
|
RU2813598C1 |
METHOD FOR EVALUATING GIVEN SEGMENTS PATENCY IN LACRIMAL APPARATUS | 2002 |
|
RU2234247C1 |
METHOD FOR SAMPLING CONTENT OF LACHRYMAL PASSAGES FOR CYTOLOGICAL ANALYSIS | 2007 |
|
RU2348934C1 |
METHOD OF CONTRASTING LACRIMAL DUCTS IN DIAGNOSIS OF CHRONIC DACRYOCYSTITIS USING COMPUTED TOMOGRAPHY OF PARANASAL SINUSES | 2023 |
|
RU2810018C1 |
METHOD OF TREATING EPIPHORA | 2009 |
|
RU2402287C1 |
METHOD FOR DIAGNOSING DACRYOSTENOSIS | 2023 |
|
RU2804696C1 |
Authors
Dates
2013-04-20—Published
2012-02-22—Filed